Live news related to NOVACYT stock (FR0010397232): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on NOVACYT mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €0,43 on Euronext Paris, down 6,21% at the last update. This page lists the articles published on NOVACYT stock to track the share price, company announcements and any item likely to influence market perception.
The molecular diagnostics specialist continues its downturn during the session, following a major internal reorganization. The punishment continues ev…
Shares of the molecular diagnostics specialist suffer a heavy penalty during the session, amid a major internal reorganization. Morning announcements …
Novacyt announces the initiation of a consultation process that could lead to a workforce reduction of up to 40% across the Group. This reorganization…
Novacyt shares rise 11.32% to €0.58 at midday in a bullish Paris market (CAC 40 +0.88%, SBF 120 +0.86%). The stock recovers after a challenging week, …
Novacyt announced on Tuesday the launch of the Yourgene Insight DPYD test, designed to identify cancer patients with a deficiency in dihydropyrimidine…
Dr. Joanne Mason resigned on Thursday from her role as Chief Scientific Officer and board member of Novacyt, to pursue other professional projects. He…
Novacyt shows slight but sustained growth. Revenue increased by 4% (5% at constant exchange rates) to reach £20.0M, slightly exceeding market expectat…
Novacyt S.A. has announced that it was notified of ordinary share purchases made by three executives in late March 2026, as part of the disclosure obl…
Novacyt announced on March 20, 2026, the closure of its capital increase with preferential subscription rights, having raised €784,736 through the iss…
Novacyt has announced the signing of an acquisition agreement for Southern Cross Diagnostics, an Australian distributor of diagnostic products. The de…
